• Home
  • Search Results
  • An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats.

An open clinical trial on the efficacy of cetirizine hydrochloride in the management of allergic pruritus in cats.

The Canadian veterinary journal = La revue veterinaire canadienne (2012-07-04)
Joya S Griffin, Danny W Scott, William H Miller, Michelle M Tranchina
ABSTRACT

Cetirizine hydrochloride was administered orally at 5 mg/cat, q24h, to 32 cats with allergic skin disease. Pruritus was reduced in 41% (13/32) of the cats. The antipruritic effect was repeatable and sustainable. There was no significant association between patient age, disease severity, or cutaneous reaction pattern and improvement during cetirizine administration. No adverse side effects were reported.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cetirizine dihydrochloride, ≥98% (HPLC)
Sigma-Aldrich
Cetirizin dihydrochloride, ≥98.0% (HPLC)
Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard
Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.